Administration Precautions
Conditions Which May Preclude Use of Spinal Anesthesia
The following conditions may preclude the use of spinal anesthesia, depending upon the physician's evaluation of the patient:
The dosage of MARCAINE SPINAL administered varies with the anesthetic procedure, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. Administer the smallest dosage and concentration required to produce the desired result.
The extent and degree of spinal anesthesia depend upon several factors including dosage, baricity of the anesthetic solution, volume of solution, force of injection, level of puncture, and position of the patient during and immediately after injection.
In recommended doses, MARCAINE SPINAL produces complete motor and sensory block.
The following table summarizes general dosage guidelines for adult patients for the procedures described:
PROCEDURES | DOSAGE GUIDELINES |
---|---|
Vaginal Delivery | Starting dose, 6 mg (0.8 mL) |
Lower Extremity and Perineal Procedures, such as:
| 7.5 mg (1 mL) |
Lower Abdominal Procedures, such as:
| 12 mg (1.6 mL) |
Cesarean Section | 7.5 mg to 10.5 mg (1 mL to 1.4 mL) |
Administration Precautions
Conditions Which May Preclude Use of Spinal Anesthesia
The following conditions may preclude the use of spinal anesthesia, depending upon the physician's evaluation of the patient:
The dosage of MARCAINE SPINAL administered varies with the anesthetic procedure, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. Administer the smallest dosage and concentration required to produce the desired result.
The extent and degree of spinal anesthesia depend upon several factors including dosage, baricity of the anesthetic solution, volume of solution, force of injection, level of puncture, and position of the patient during and immediately after injection.
In recommended doses, MARCAINE SPINAL produces complete motor and sensory block.
The following table summarizes general dosage guidelines for adult patients for the procedures described:
PROCEDURES | DOSAGE GUIDELINES |
---|---|
Vaginal Delivery | Starting dose, 6 mg (0.8 mL) |
Lower Extremity and Perineal Procedures, such as:
| 7.5 mg (1 mL) |
Lower Abdominal Procedures, such as:
| 12 mg (1.6 mL) |
Cesarean Section | 7.5 mg to 10.5 mg (1 mL to 1.4 mL) |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.